show the area quantification (expressed in percentage) of three independent experiments (wound healing assay) performed in 786-0 cell line. Cells were pretreated with GM6001 (20 µM) A. or cytarabine (100 µM) B. After 30 minutes, pro-BDNF (20 ng/mL) was added to culture media (in serum deprivation conditions), and migration was evaluated at 24 hours. C. Viability at 24 hours was evaluated by XTT in 786-O cell line in presence of Cytarabine (Sigma-aldrich, European Pharmacopeia -EP-C3350000) at indicate doses. Results are represented as mean ± SEM of at least three independent experiments performed in triplicate. Differences were considered to be significant at *p<0.05 or **p<0.01 level.
